Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-006427

Chief Development Officer acquired 28,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Michaelson Jennifer · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-11 Grant or award : show line 1 in the form +28,500 51,411 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-11 Grant or award : show line 2 in the form Stock Option (Right to Buy) +57,000 57,000 D
Loading xslF345X03/doc4.xml…